Dolutegravir 25 mg and 50 mg and Ketoprofen Extended-Release Capsules
Determining the interaction of Dolutegravir 25 mg and 50 mg and Ketoprofen Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dolutegravir
Brand name: Tivicay
Synonyms: Dolutegravir
Generic Name: ketoprofen
Brand name: Oruvail, Orudis, Actron, Orudis KT
Synonyms: Ketoprofen
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dolutegravir 25 mg and 50 mg-Ketorolac
- Dolutegravir 25 mg and 50 mg-Ketorolac (Systemic)
- Dolutegravir 25 mg and 50 mg-Ketorolac Eye Drops (Multi-Dose Containers)
- Dolutegravir 25 mg and 50 mg-Ketorolac Eye Drops (Single-Dose Containers)
- Dolutegravir 25 mg and 50 mg-Ketorolac Injection
- Dolutegravir 25 mg and 50 mg-Ketorolac nasal
- Ketoprofen Extended-Release Capsules-Dolutegravir and lamivudine
- Ketoprofen Extended-Release Capsules-Dolutegravir and rilpivirine
- Ketoprofen Extended-Release Capsules-Dolutegravir Sodium
- Ketoprofen Extended-Release Capsules-Dolutegravir Sodium And Lamivudine
- Ketoprofen Extended-Release Capsules-Dolutegravir Sodium and Rilpivirine Hydrochloride
- Ketoprofen Extended-Release Capsules-Dom-Etoposide